| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/02/2009 | WO2009014382A3 Cxcl11 adjuvant compositions and uses thereof |
| 04/02/2009 | WO2009011941A3 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 04/02/2009 | WO2009005809A3 Compositions and methods for treating and diagnosing cancer |
| 04/02/2009 | WO2008150490A3 Uses and compositions for treatment of psoriasis and crohn's disease |
| 04/02/2009 | WO2008150485A3 Erbb2 binding proteins and use thereof |
| 04/02/2009 | WO2008142483A3 Vaccine compositions and methods of use thereof |
| 04/02/2009 | WO2008140653A3 Humaneered anti-factor b antibody |
| 04/02/2009 | WO2008124647A3 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
| 04/02/2009 | WO2008124646A3 Use of amyloid proteins as vaccine scaffolds |
| 04/02/2009 | WO2008057550A3 Stabilization of vaccines by lyophilization |
| 04/02/2009 | WO2008051448A3 Methods and compositions for efficient removal of protein a from binding molecule preparations |
| 04/02/2009 | WO2007115150A3 Binding partners with immunoglobulin domains modified to have extended half-life |
| 04/02/2009 | WO2007046811A3 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 04/02/2009 | WO2006098769A3 Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers |
| 04/02/2009 | WO2006004910A3 Improved bispecific antibodies |
| 04/02/2009 | WO2005097169A3 Novel immunotherapy |
| 04/02/2009 | WO2005081716A3 DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) |
| 04/02/2009 | WO2005054433A3 A novel “cleave-n-read” system for protease activity assay and methods of use thereof |
| 04/02/2009 | WO2005033291A3 Hormone response element binding transregulators |
| 04/02/2009 | WO2004096156A3 Toll-like receptor 9 effector agents and uses thereof |
| 04/02/2009 | WO2004080394A3 Stat3 antagonists and their use as vaccines against cancer |
| 04/02/2009 | US20090088558 Tumor necrosis factor specific antibody hybrid for use in treatment and prevention of autoimmune, rheumatoid arthritic, graft rejection and graft-versus-host disorder |
| 04/02/2009 | US20090088390 Polypeptide |
| 04/02/2009 | US20090088384 Therapeutic Fibrin-Derived Peptides And Uses Thereof |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087494 Methods and Compositions for Targeted Delivery of Therapeutic Agents |
| 04/02/2009 | US20090087493 Supramolecular Functionalization of Graphitic Nanoparticles for Drug Delivery |
| 04/02/2009 | US20090087478 Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them |
| 04/02/2009 | US20090087459 Methods for treating eye disorders |
| 04/02/2009 | US20090087458 Activatable recombinant neurotoxins |
| 04/02/2009 | US20090087457 Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins |
| 04/02/2009 | US20090087456 Adjuvanted vaccine |
| 04/02/2009 | US20090087455 preventing an obesity-related disease due to an adipogenic adenovirus by administering a vaccine composition |
| 04/02/2009 | US20090087454 Method for therapeutic, clinical and veterinary use Poly-ICLC |
| 04/02/2009 | US20090087453 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 04/02/2009 | US20090087452 Methods and apparatus for the production of viral vaccines |
| 04/02/2009 | US20090087451 Methods and Compositions for Vaccination |
| 04/02/2009 | US20090087450 Combination therapy of hybrid cells with BCG injection for treating Cancer Patients |
| 04/02/2009 | US20090087449 Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus |
| 04/02/2009 | US20090087448 Stable Immunoprophylactic and Therapeutic Compositions Derived From Transgenic Plant Cells and Methods for Production |
| 04/02/2009 | US20090087447 Novel HCV non-structural polypeptide |
| 04/02/2009 | US20090087446 Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/02/2009 | US20090087445 Method for the Redox Potential-Dependent Detection of Target Molecules by Interacting Polypeptides |
| 04/02/2009 | US20090087444 Pharmaceutical composition comprising polysaccharides from angelica gigas nakai for activation of dendritic cells |
| 04/02/2009 | US20090087443 Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery |
| 04/02/2009 | US20090087442 antibody designated RM4 and selectively binds to an antigen designated AgRM4; for treament of neoplasia; competitive binding; kits |
| 04/02/2009 | US20090087441 treating lung cancer with PI-3 kinase inhibitor acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta ,12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta [ alpha ]phenanthren-11-yl ester |
| 04/02/2009 | US20090087440 Methods for Treating Cancer |
| 04/02/2009 | US20090087439 Compositions and methods for diagnosing or treating psoriasis |
| 04/02/2009 | US20090087438 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 04/02/2009 | US20090087437 Methods and compositions relating to the regulation of apoptosis by muc1 and bh3-containing proapoptotic proteins |
| 04/02/2009 | US20090087436 Compositions and methods for treating diseases |
| 04/02/2009 | US20090087435 Isolated Chimeric Proteins Of Modified Lumazine Synthase |
| 04/02/2009 | US20090087434 Nfia in glial fate determination, glioma therapy and astrocytoma treatment |
| 04/02/2009 | US20090087433 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/02/2009 | US20090087432 TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES |
| 04/02/2009 | US20090087431 Methods of treating bone disorders with modulators of axl |
| 04/02/2009 | US20090087430 Selective inhibition of toll-like receptor-2 |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087428 Anti-fc-gamma riib receptor antibody and uses therefor |
| 04/02/2009 | US20090087427 Biological materials and uses thereof |
| 04/02/2009 | US20090087426 Methods for Treatment of Allergic Asthma |
| 04/02/2009 | US20090087425 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 04/02/2009 | US20090087424 Modulating Retinal Pigmented Epithelium Permeaion By Inhibiting Or Activating VEGFR-1 |
| 04/02/2009 | US20090087423 Novel protein complex and use thereof |
| 04/02/2009 | US20090087410 Treatment of hypersensitivity |
| 04/02/2009 | US20090087407 Methods for the treatment of scleroderma using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| 04/02/2009 | US20090087406 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |
| 04/02/2009 | US20090087404 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/02/2009 | US20090087403 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/02/2009 | US20090087388 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 04/02/2009 | US20090087375 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/02/2009 | DE102008049320A1 Use of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (HER2/neu) antagonists for treating restenosis after angioplasty or after placing a stent into a vessel |
| 04/02/2009 | CA2704153A1 Vaccine for rsv and mpv |
| 04/02/2009 | CA2704134A1 Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| 04/02/2009 | CA2700986A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 04/02/2009 | CA2700942A1 An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases |
| 04/02/2009 | CA2700892A1 Reagents for inducing an immune response |
| 04/02/2009 | CA2700810A1 Immunoliposomes for treatment of cancer |
| 04/02/2009 | CA2700723A1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 04/02/2009 | CA2700701A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | CA2700673A1 Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors |
| 04/02/2009 | CA2700665A1 Combination therapy for the treatment of cancer using cox-2 inhibitors and dual inhibitors of egfr [erbb1] and her-2 [erbb2] |
| 04/02/2009 | CA2700604A1 Rna vaccines |
| 04/02/2009 | CA2700498A1 Anti-il-6 receptor antibody |
| 04/02/2009 | CA2700481A1 Antigen binding proteins |
| 04/02/2009 | CA2700394A1 Modified antibody constant region |
| 04/02/2009 | CA2700351A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 04/02/2009 | CA2700129A1 Vaccines and vaccine components for inhibition of microbial cells |
| 04/02/2009 | CA2698920A1 Vaccine for the treatment of osteoarthritis |
| 04/02/2009 | CA2698609A1 Novel antibodies |
| 04/02/2009 | CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same |
| 04/01/2009 | EP2042869A2 High affinity TCR proteins and methods |
| 04/01/2009 | EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use |
| 04/01/2009 | EP2042604A1 VV promoter driven overexpression of recombinant antigens |
| 04/01/2009 | EP2042600A1 A public and immunogenic CD4+ T Cell epitope of the hiv tat protein and its applications |
| 04/01/2009 | EP2042599A1 Method of making microencapsulated DNA for vaccination and gene therapy |
| 04/01/2009 | EP2042598A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |